Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression vulnerability and 5-hydroxytryptophan prophylaxis.

H van Praag, S de Hann

    Psychiatry Research
    |September 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The effect of supraphysiological dose of nandrolone decanoate administration on the inflammatory, neurotrophin and behavioral response in adult and old male mice.

    Hormones and behavior·2024
    Same author

    JNK1 controls adult hippocampal neurogenesis and imposes cell-autonomous control of anxiety behaviour from the neurogenic niche.

    Molecular psychiatry·2017
    Same author

    JNK1 controls adult hippocampal neurogenesis and imposes cell-autonomous control of anxiety behaviour from the neurogenic niche.

    Molecular psychiatry·2016
    Same author

    Plant-derived flavanol (-)epicatechin mitigates anxiety in association with elevated hippocampal monoamine and BDNF levels, but does not influence pattern separation in mice.

    Translational psychiatry·2015
    Same author

    Serotonin-related, anxiety/aggression-driven, stressor-precipitated depression. A psycho-biological hypothesis.

    European psychiatry : the journal of the Association of European Psychiatrists·2009
    Same author

    Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo.

    Neuroscience·2004
    Same journal

    Effect of Australian telepsychiatry services on attention-deficit hyperactivity disorder prescriptions.

    Psychiatry research·2026
    Same journal

    Cognitive correlates of Antisaccade Task performance in bipolar disorder.

    Psychiatry research·2026
    Same journal

    National estimates of exposure to potentially traumatic events among individuals with obsessive-compulsive disorder: Findings from The National OCD Survey.

    Psychiatry research·2026
    Same journal

    Digitally delivered cognitive bias modification for interpretation targeting hostile interpretation bias in compulsory drug rehabilitation: A feasibility randomized trial.

    Psychiatry research·2026
    Same journal

    Association of TyG-RFM with depressive symptoms: a nationally representative study enhanced by interpretable machine learning.

    Psychiatry research·2026
    Same journal

    Cross-national patterns of probable complex PTSD in post-communist Europe: A network analysis of five countries.

    Psychiatry research·2026
    See all related articles

    5-Hydroxytryptophan (5-HTP) reduces relapse rates in recurrent depression by addressing central serotonin deficiency. This marks a significant advancement in targeted psychiatric chemoprophylaxis.

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Pharmacology

    Background:

    • Vital depressions may involve a central serotonin (5-hydroxytryptamine; 5-HT) deficiency.
    • Treatments like 5-hydroxytryptophan (5-HTP) or clomipramine can alleviate symptoms by targeting this deficiency.
    • Persistent 5-HT deficiency suggests a predisposing factor rather than a direct cause of depression.

    Purpose of the Study:

    • To investigate the prophylactic effect of 5-HTP in preventing relapse in recurrent vital depressions.
    • To determine if targeting central 5-HT metabolism can offer a preventative strategy for depression.

    Main Methods:

    • Administered 5-HTP to patients with recurrent vital depressions (unipolar and bipolar courses).
    • Monitored relapse rates in patients receiving 5-HTP prophylaxis.

    Related Experiment Videos

  • Correlated prophylactic effects with the persistence of central 5-HT metabolism disorders.

    • Main Results:

    • 5-HTP significantly reduced the relapse rate in recurrent vital depressions.
    • The prophylactic effect was most notable in patients with persistent central 5-HT metabolism disturbances.
    • This study introduces the first pathological substrate-oriented chemoprophylaxis in psychiatry.

    Conclusions:

    • 5-HTP demonstrates a prophylactic effect against depression relapse, particularly in individuals with persistent serotonin deficiency.
    • Targeting specific metabolic pathways, like serotonin metabolism, offers a promising avenue for psychiatric chemoprophylaxis.
    • Further research is needed to corroborate the enhanced effect in patients with persistent 5-HT disorders.